ID

20457

Description

Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention; ODM derived from: https://clinicaltrials.gov/show/NCT00611286

Lien

https://clinicaltrials.gov/show/NCT00611286

Mots-clés

Versions (1)
  1. 23/02/2017 23/02/2017 -
Téléchargé le

23 février 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Coronary Artery Disease NCT00611286

Anglais

Eligibility Coronary Artery Disease NCT00611286

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. males or females ≥ 18 years of age with coronary artery disease with low, intermediate or high-risk coronary anatomy, which is considered suitable for pci with stent placement.
Description

Age | Coronary Artery Disease | Anatomy Coronary Low Risk | Anatomy Coronary Intermediate Risk | Anatomy Coronary High risk | Percutaneous Coronary Intervention Amenable | Placement of stent Amenable

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C1956346
UMLS CUI [3,1]
C1384516
UMLS CUI [3,2]
C1522318
UMLS CUI [3,3]
C3538919
UMLS CUI [4,1]
C1384516
UMLS CUI [4,2]
C1522318
UMLS CUI [4,3]
C3640764
UMLS CUI [5,1]
C1384516
UMLS CUI [5,2]
C1522318
UMLS CUI [5,3]
C0332167
UMLS CUI [6,1]
C1532338
UMLS CUI [6,2]
C3900053
UMLS CUI [7,1]
C0522776
UMLS CUI [7,2]
C3900053
2. subjects who have provided written informed consent prior to initiation of any study-related procedures, prior to receiving any pre-procedural sedation and who agree to comply with all protocol-specified procedures.
Description

Informed Consent | Protocol Compliance

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0525058
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. women who are pregnant. women of childbearing potential must have a negative pregnancy test (urine or serum hcg) within 7 days prior to randomization; as close to randomization as possible, within 24 hours preferred.
Description

Pregnancy | Childbearing Potential Urine pregnancy test negative | Childbearing Potential Serum pregnancy test (B-HCG) Negative

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0430057
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0430060
UMLS CUI [3,3]
C1513916
2. allergy or intolerance to aspirin, or both clopidogrel and ticlopidine
Description

Aspirin allergy | Hypersensitivity clopidogrel | Hypersensitivity Ticlopidine | aspirin intolerance | intolerance to clopidogrel | intolerance to Ticlopidine

Type de données

boolean

Alias
UMLS CUI [1]
C0004058
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0070166
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0040207
UMLS CUI [4]
C0004059
UMLS CUI [5,1]
C1744706
UMLS CUI [5,2]
C0070166
UMLS CUI [6,1]
C1744706
UMLS CUI [6,2]
C0040207
3. subjects with a contraindication to anticoagulation and/or increased bleeding risk:
Description

Medical contraindication Anticoagulation | Bleeding Risk Increased

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0003281
UMLS CUI [2,1]
C3251812
UMLS CUI [2,2]
C0205217
past or present bleeding disorder including a history of the following within 1 month prior to randomization: clinically relevant gastrointestinal bleeding, gross (visible) hematuria,
Description

Blood Coagulation Disorders | Gastrointestinal Hemorrhage | Frank hematuria

Type de données

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2]
C0017181
UMLS CUI [3]
C0473237
planned major surgery including cabg after or within 1 month prior to randomization.
Description

major surgery Planned | Coronary Artery Bypass Surgery

Type de données

boolean

Alias
UMLS CUI [1,1]
C0679637
UMLS CUI [1,2]
C1301732
UMLS CUI [2]
C0010055
any subject with a known coagulopathy, platelet disorder, or history of thrombocytopenia.
Description

Blood Coagulation Disorders | Blood Platelet Disorders | Thrombocytopenia

Type de données

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2]
C0005818
UMLS CUI [3]
C0040034
4. subjects with a history of cancer (limiting survival) not known to be disease free, with the exception of basal cell carcinoma of the skin.
Description

Malignant Neoplasms Continuance of life Limiting | Basal cell carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0038952
UMLS CUI [1,3]
C0439801
UMLS CUI [2]
C0007117
5. history of clinically important, recent or ongoing alcohol abuse or other drug abuse.
Description

Substance Use Disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0038586
6. known platelet count <100,000/mm3 (<100 x 109/l).
Description

Platelet Count measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0032181
7. subjects who is unable to give informed consent and assurance for complete contact through 2 years.
Description

Informed Consent Unable | Compliance behavior Limited

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C1321605
UMLS CUI [2,2]
C0439801
Retour au début de la page

Similar models

Eligibility Coronary Artery Disease NCT00611286

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age | Coronary Artery Disease | Anatomy Coronary Low Risk | Anatomy Coronary Intermediate Risk | Anatomy Coronary High risk | Percutaneous Coronary Intervention Amenable | Placement of stent Amenable
Item
1. males or females ≥ 18 years of age with coronary artery disease with low, intermediate or high-risk coronary anatomy, which is considered suitable for pci with stent placement.
boolean
C0001779 (UMLS CUI [1])
C1956346 (UMLS CUI [2])
C1384516 (UMLS CUI [3,1])
C1522318 (UMLS CUI [3,2])
C3538919 (UMLS CUI [3,3])
C1384516 (UMLS CUI [4,1])
C1522318 (UMLS CUI [4,2])
C3640764 (UMLS CUI [4,3])
C1384516 (UMLS CUI [5,1])
C1522318 (UMLS CUI [5,2])
C0332167 (UMLS CUI [5,3])
C1532338 (UMLS CUI [6,1])
C3900053 (UMLS CUI [6,2])
C0522776 (UMLS CUI [7,1])
C3900053 (UMLS CUI [7,2])
Informed Consent | Protocol Compliance
Item
2. subjects who have provided written informed consent prior to initiation of any study-related procedures, prior to receiving any pre-procedural sedation and who agree to comply with all protocol-specified procedures.
boolean
C0021430 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Childbearing Potential Urine pregnancy test negative | Childbearing Potential Serum pregnancy test (B-HCG) Negative
Item
1. women who are pregnant. women of childbearing potential must have a negative pregnancy test (urine or serum hcg) within 7 days prior to randomization; as close to randomization as possible, within 24 hours preferred.
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0430057 (UMLS CUI [2,2])
C3831118 (UMLS CUI [3,1])
C0430060 (UMLS CUI [3,2])
C1513916 (UMLS CUI [3,3])
Aspirin allergy | Hypersensitivity clopidogrel | Hypersensitivity Ticlopidine | aspirin intolerance | intolerance to clopidogrel | intolerance to Ticlopidine
Item
2. allergy or intolerance to aspirin, or both clopidogrel and ticlopidine
boolean
C0004058 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0070166 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0040207 (UMLS CUI [3,2])
C0004059 (UMLS CUI [4])
C1744706 (UMLS CUI [5,1])
C0070166 (UMLS CUI [5,2])
C1744706 (UMLS CUI [6,1])
C0040207 (UMLS CUI [6,2])
Medical contraindication Anticoagulation | Bleeding Risk Increased
Item
3. subjects with a contraindication to anticoagulation and/or increased bleeding risk:
boolean
C1301624 (UMLS CUI [1,1])
C0003281 (UMLS CUI [1,2])
C3251812 (UMLS CUI [2,1])
C0205217 (UMLS CUI [2,2])
Blood Coagulation Disorders | Gastrointestinal Hemorrhage | Frank hematuria
Item
past or present bleeding disorder including a history of the following within 1 month prior to randomization: clinically relevant gastrointestinal bleeding, gross (visible) hematuria,
boolean
C0005779 (UMLS CUI [1])
C0017181 (UMLS CUI [2])
C0473237 (UMLS CUI [3])
major surgery Planned | Coronary Artery Bypass Surgery
Item
planned major surgery including cabg after or within 1 month prior to randomization.
boolean
C0679637 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0010055 (UMLS CUI [2])
Blood Coagulation Disorders | Blood Platelet Disorders | Thrombocytopenia
Item
any subject with a known coagulopathy, platelet disorder, or history of thrombocytopenia.
boolean
C0005779 (UMLS CUI [1])
C0005818 (UMLS CUI [2])
C0040034 (UMLS CUI [3])
Malignant Neoplasms Continuance of life Limiting | Basal cell carcinoma
Item
4. subjects with a history of cancer (limiting survival) not known to be disease free, with the exception of basal cell carcinoma of the skin.
boolean
C0006826 (UMLS CUI [1,1])
C0038952 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0007117 (UMLS CUI [2])
Substance Use Disorders
Item
5. history of clinically important, recent or ongoing alcohol abuse or other drug abuse.
boolean
C0038586 (UMLS CUI [1])
Platelet Count measurement
Item
6. known platelet count <100,000/mm3 (<100 x 109/l).
boolean
C0032181 (UMLS CUI [1])
Informed Consent Unable | Compliance behavior Limited
Item
7. subjects who is unable to give informed consent and assurance for complete contact through 2 years.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial